Full-Life Technologies
PrivateLast Round
Series D
May 18, 2026
Total Funding Raised
$297.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Full-Life Technologies operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series D round in May 2026.
Full-Life Technologies is a biotechnology company that develops and commercializes precision nuclear medicines and radionuclide-drug conjugates for cancer therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Pharma Supply Chain
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Full-Life Technologies Comparables
Compare Full-Life Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ARTBIO | 90% | |
| AdvanCell | 88% | |
| Alpha-9 Oncology | 87% |
For institutional investors. Book with your work email.
Full-Life Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 18, 2026 | ||||
| Debt | Sep 30, 2025 | ||||
| Series C | Sep 30, 2025 | ||||
| Series B | Jan 3, 2024 | ||||
| Debt | Jan 3, 2024 | ||||
Series A | May 26, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Full-Life Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CD Capital Asset Management | Series A |
| Summer Capital | Series C, Series B |
| Guanghua Wutong Fund | Series B |
| Junson Capital | Series D, Series C, Series A, Series B |
| Lapam Capital | Series C |
| Yunion Health Investments | Series A |
| Sky9 Capital | Series D, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Lead asset 225Ac-FL-020 received designation for mCRPC treatment.
- May 18, 2026
$110M round led by Vivo Capital.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 23, 2026
Full-Life Technologies Limited presents encouraging preliminary phase 1 results on FL-020’s safety and PSA reduction in metastatic castration-resistant prostate cancer at ESMO 2026 in Spain on Oct 23rd '26.
For institutional investors. Book with your work email.
Full-Life Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Full-Life Technologies's valuation, stock price, and market status.
Is Full-Life Technologies a public or private company?
Full-Life Technologies is a private company.
What is the current stock price of Full-Life Technologies?
Full-Life Technologies is a private company, so its shares have no public market price. Caplight tracks Full-Life Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Full-Life Technologies worth (valuation)?
Valuation information for Full-Life Technologies is not publicly available.
Can I buy Full-Life Technologies stock?
Full-Life Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Full-Life Technologies's last funding round?
Full-Life Technologies's most recent funding round was Series D on May 18, 2026.
Who are the main investors in Full-Life Technologies?
Key investors in Full-Life Technologies include Summer Capital, Junson Capital, Sky9 Capital, Chengwei Capital, Aramco Ventures.
Will Full-Life Technologies IPO soon?
No public IPO plans have been announced for Full-Life Technologies.
How can I track Full-Life Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Full-Life Technologies's shares on secondary markets.